Migraine Clinical Trials in New York

Showing 81-100 of 151 trials

A Study of Home-Delivered Neurostimulation for Migraine

NCT03874351

There is a need for better preventive and abortive therapies for migraine. Previous research has indicated that non-invasive neurostimulation may have prophylactic effects on migraine and improve symptoms and functional outcomes in migraineurs. One such method is a non-invasive transcranial direct current stimulation (tDCS). This double-blind randomized sham-controlled two-parallel-arm study aims to evaluate efficacy and safety of tDCS self-delivered in daily 20-minute applications for 2 months (60 days) by adult migraine patients at home for migraine prevention and migraine symptom management, as compared to sham tDCS application; and to evaluate patients' satisfaction with the procedure.

Migraine Disorders

MJHS Institute for Innovation in Palliative Care22 participantsStarted Apr 2019

New York, New York, United States • New York, New York, United States

TERMINATEDPhase 3< 1 mile

A Study Comparing the Efficacy and Safety of Fremanezumab (TEV-48125) for the Prevention of Chronic Cluster Headache (CCH)

NCT02964338

The purpose of the current study is to evaluate the efficacy and safety of Fremanezumab (TEV-48125), in the prevention of CCH in adult participants.

Chronic Cluster Headache

Teva Branded Pharmaceutical Products R&D, Inc.259 participantsStarted Jan 2017

Phoenix, Arizona, United States • Canoga Park, California, United States • Santa Monica, California, United States +80 more locations

A Study of Home-Delivered Neurostimulation for Migraine

A Study Comparing the Efficacy and Safety of Fremanezumab (TEV-48125) for the Prevention of Chronic Cluster Headache (CCH)

Migraine Trials in Other Cities

A Study to Evaluate the Efficacy and Safety of TEV-48125 (Fremanezumab) for the Prevention of Episodic Cluster Headache (ECH)

A Study to Explore the Long-Term Safety and Efficacy of Fremanezumab (TEV-48125) for the Prevention of Cluster Headache

Safety and Efficacy of Nerivio™ for the Acute Treatment of Migraine in Adolescents

Occipital Nerve Stimulation (ONS) for Migraine: OPTIMISE

A Study to Evaluate the Efficacy and Safety of Eptinezumab Administered Intravenously in Participants Experiencing Acute Attack of Migraine

SPG Block for Acute Pediatric Migraine

Assessment of LBR-101 In Chronic Migraine

Metoclopramide for Post Traumatic Headache

Greater Occipital Nerve Block Versus Metoclopramide

Intranasal Lidocaine to Treat Pediatric Migraine in the Emergency Department

Musculoskeletal Impairment in Headaches Attributed to Rhinosinusitis

Safety and Efficacy of NPS 1776 in the Acute Treatment of Migraine Headaches

A Study of Galcanezumab (LY2951742) in Adults With Treatment-Resistant Migraine

An Efficacy and Safety Study of Fremanezumab in Adults With Migraine

Study of Pediatric Migraine: The Pediatric Migraine Registry

PREMIUM Migraine Trial

Efficacy and Safety of Eletriptan for the Treatment of Migraine in Patients Not Satisfied With Rizatriptan Therapy

Efficacy and Safety of BGG492 in the Treatment of Migraine

Other Conditions in New York